Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis.
暂无分享,去创建一个
Mitsutoshi Nakamura | K. Shimada | N. Konishi | Keiji Shimada | Mitsutoshi Nakamura | Noboru Konishi | Syuichi Matsuyoshi | Eiwa Ishida | Munehiro Kishi | S. Matsuyoshi | E. Ishida | M. Kishi
[1] P. de Souza,et al. Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine. , 1997, British Journal of Cancer.
[2] David W. Anderson,et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Ott,et al. Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines. , 1999, Cancer letters.
[4] E. Solary,et al. Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs* , 1999, The Journal of Biological Chemistry.
[5] T. Garrington,et al. MEK Kinase 1 (MEKK1) Transduces c-Jun NH2-terminal Kinase Activation in Response to Changes in the Microtubule Cytoskeleton* , 1999, The Journal of Biological Chemistry.
[6] A. Bird,et al. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. T. Abreu-Martin,et al. Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer , 1999, Molecular and Cellular Biology.
[8] Mitsutoshi Nakamura,et al. Contributions of mitogen‐activated protein kinase and nuclear factor kappa B to N‐(4‐hydroxyphenyl)retinamide–induced apoptosis in prostate cancer cells , 2002, Molecular carcinogenesis.
[9] T. Kuroki,et al. Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells , 2002 .
[10] E. Hall,et al. Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.
[11] S. Nagata,et al. The Fas death factor , 1995, Science.
[12] P. Krammer,et al. CD95's deadly mission in the immune system , 2000, Nature.
[13] P. Schiff,et al. Taxol and radiation. , 1993, Journal of the National Cancer Institute. Monographs.
[14] R. Gaynor,et al. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.
[15] S. Fuqua,et al. Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function , 2002, Molecular and Cellular Biology.
[16] H. Ichijo,et al. From receptors to stress-activated MAP kinases , 1999, Oncogene.
[17] M. Jordan,et al. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. , 1998, Current opinion in cell biology.
[18] A. Winoto,et al. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. , 2003, Immunity.
[19] T. Kuroki,et al. Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. , 2002, The Journal of clinical investigation.
[20] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[21] C. Widmann,et al. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1 , 1997, Oncogene.
[22] Mitsutoshi Nakamura,et al. c‐Jun NH2‐terminal kinase‐dependent fas activation contributes to etoposide‐induced apoptosis in p53‐mutated prostate cancer cells , 2003, The Prostate.
[23] T. Fojo,et al. Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways* , 1998, The Journal of Biological Chemistry.
[24] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[25] T. H. Wang,et al. Paclitaxel‐induced cell death , 2000, Cancer.
[26] C. Widmann,et al. MEK Kinase 1, a Substrate for DEVD-Directed Caspases, Is Involved in Genotoxin-Induced Apoptosis , 1998, Molecular and Cellular Biology.
[27] M. Peter,et al. Phosphorylation of FADD/ MORT1 at Serine 194 and Association with a 70-kDa Cell Cycle-Regulated Protein Kinase1 , 2000, The Journal of Immunology.
[28] Mitsutoshi Nakamura,et al. Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells , 2002, Japanese journal of cancer research : Gann.
[29] C. Widmann,et al. Differential Involvement of MEK Kinase 1 (MEKK1) in the Induction of Apoptosis in Response to Microtubule-targeted Drugsversus DNA Damaging Agents* , 1999, The Journal of Biological Chemistry.
[30] Mitsutoshi Nakamura,et al. Requirement of c‐jun for testosterone‐induced sensitization to N‐(4‐hydroxyphenyl)retinamide–induced apoptosis , 2003, Molecular carcinogenesis.